Allogeneic transplantation of hematopoietic cells is an effective treatment of leukemia, even
in advanced stages. Allogeneic lymphocytes produce a strong graft-versus-leukemia (GVL) …

The oligometastatic paradigm implies that patients who develop a small number of
metastatic lesions might achieve long-term survival if all these lesions are ablated with …

Abstract The China Assessment of Antifungal Therapy in Hematological Disease study, the
first large-scale observational study of invasive fungal disease (IFD) in China, enrolled 1401 …

Background Allogeneic hematopoietic stem cell transplantation from haploidentical donor is
a feasible option for patients with hematological diseases who lack a suitable HLA-matched …

Ocular involvement can be quite symptomatic in patients with chronic graft-versus-host
disease (GVHD). The prevalence of and risk factors for ocular GVHD and its impact on …

Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a curative treatment
option for both malignant and some benign hematological diseases. During the last decade …

High-risk neuroblastoma is a childhood malignancy with a poor prognosis. Gradual
improvements in survival have correlated with therapeutic intensity, and the ability to …

Background: An allogeneic antitumour effect has been reported for various cancers. We
evaluated the experience of allogeneic haematopoietic stem cell transplantation (HSCT) for …

Background: The outcome for patients with recurrent or progressive Ewing's sarcoma family
of tumours (ESFT) is poor. High dose therapy (HDT) has been used for a number of years in …

Stem cells can be either totipotent, pluripotent, multipotent or unipotent. Totipotent cells have
the capability to produce all cell types of the developing organism, including both embryonic …